New study by WHO Europe and ECDC examines variations in antibiotic consumption in European countries between 2014 and 2018

The study focuses on data from 30 EU/EEA countries of the European Surveillance of Antibiotic Consumption Network (ESAC-Net) and 15 countries of the WHO Europe Antimicrobial Medicines Consumption (AMC) Network, and aimed at examining the total consumption and patterns of consumption of antibiotics, i.e.

Metadata

Provider:

URL:

https://www.ecdc.europa.eu/en/news-events/new-study-who-europe-and-ecdc-examines-variations-antibiotic-consumption

Retrieved on:

Wednesday, July 7, 2021

Information

Tags:

Branches of biology, Health sciences, Health, Penicillins, Cephalosporin, Enones, Antibiotic, Antimicrobial, Consumption, American Motors Corporation

Summary

Key Points:

The study focuses on data from 30 EU/EEA countries of the European Surveillance of Antibiotic Consumption Network (ESAC-Net) and 15 countries of the WHO Europe Antimicrobial Medicines Consumption (AMC) Network, and aimed at examining the total consumption and patterns of consumption of antibiotics, i.e.
However, there were considerable differences in the consumption of various antibiotic groups, with a larger consumption of penicillins and tetracyclines and a lower consumption of cephalosporins and quinolones in ESAC-Net countries than in WHO Europe AMC Network countries.
For the 15 WHO Europe AMC Network countries, parenteral formulations comprised between 2.8% and 40.1% of total consumption.
Furthermore, Access antibiotics represented more than 60% of total consumption in 17 of 29 ESAC-Net countries, and three of 15 WHO Europe AMC Network countries.